Received Apr 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
His warts and other HPV symptoms have subsided since treatment. No additional AE/PQC.; No additional AE; Since being treated with GARDASIL 9, he has had no HPV symptoms; This spontaneous report was received from a male patient of unknown age concerning to himself. The patient's medical history included human papillomavirus (HPV) and Warts. The patient's concurrent conditions were not reported. The patient did not have drug reactions or allergies, nor Concomitant therapies. On an unknown date, the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), Injection 0.5 mL (lot #, expiration date, route of administration, anatomical location not provided) for therapeutic reasons (product use for unapproved indication). The patient stated that he was very pleased as he had 27 years of history of warts and HPV and had tried many different treatments (unspecified); but his symptoms had subsided since treatment with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9), and had had no HPV symptoms (Therapeutic response unexpected). The patient thought that more patients should be using the vaccine for these therapeutic reasons. No additional adverse event was reported.
Medical History/Concurrent Conditions: HPV infection; Warts